Bukwang Pharm (003000) — Cash Flow Reinvestment Rate
Bukwang Pharm (003000) has a Cash Flow Reinvestment Rate of 2.10x as of June 2025, reinvesting ₩21.05 Billion (capex ₩2.80 Billion plus investments ₩-18.25 Billion) from operating cash flow of ₩10.03 Billion. Explore reinvestment intensity of Bukwang Pharm to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bukwang Pharm Cash Flow Reinvestment Rate (2007–2024)
Historical reinvestment intensity for Bukwang Pharm across 10 annual periods. Also explore Bukwang Pharm total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Bukwang Pharm (2007–2024)
Year-by-year capital reinvestment analysis for Bukwang Pharm. For live market cap and broader valuation context, see 003000 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.17x | ₩40.11 Billion | ₩34.36 Billion | ₩2.61 Billion | ▲ +136.0% |
| 2022 | 0.49x | ₩8.14 Billion | ₩16.46 Billion | ₩4.99 Billion | ▲ +121.0% |
| 2021 | 0.22x | ₩5.94 Billion | ₩26.52 Billion | ₩785.05 Million | ▼ -96.8% |
| 2020 | 7.09x | ₩5.13 Billion | ₩723.17 Million | ₩1.92 Billion | ▲ +14.4% |
| 2018 | 6.20x | ₩42.27 Billion | ₩6.82 Billion | ₩3.71 Billion | ▲ +830.9% |
| 2017 | 0.67x | ₩5.70 Billion | ₩8.56 Billion | ₩4.49 Billion | ▼ -25.6% |
| 2015 | 0.89x | ₩9.21 Billion | ₩10.30 Billion | ₩4.58 Billion | ▲ +343.3% |
| 2014 | 0.20x | ₩5.62 Billion | ₩27.86 Billion | ₩2.97 Billion | ▼ -76.3% |
| 2013 | 0.85x | ₩31.14 Billion | ₩36.52 Billion | ₩3.74 Billion | ▲ +14.9% |
| 2007 | 0.74x | ₩20.69 Billion | ₩27.87 Billion | ₩20.69 Billion | — |